About Hospital General de Castellon; Servicio de Hematologia
El Hospital General Universitario de Castellón es el hospital de referencia de Castelló de la Plana y de su provincia. El Hospital General es el principal centro de referencia del Departamento de Salud de Castellón.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Clinical Trials at Hospital General de Castellon; Servicio de Hematologia
During the past decade, Hospital General de Castellon; Servicio de Hematologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.
2006-09-04
2011-05-26
Completed
545
A Study to Assess the Efficacy of Rituximab (MabThera) in First Line Treatment of Chronic Lymphocytic Leukemia (CLL)
2007-11-21
2016-05-20
Completed
86
MabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Rituximab During First-Line Treatment for Lymphoma
2013-11-11
2017-04-11
Completed
140
A Study Evaluating the Efficacy of Obinutuzumab and Bendamustine Treatment in Participants With Refractory or Relapsed Chronic Lymphocytic Leukemia
2014-04-09
2018-11-19
Completed
72
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hospital General de Castellon; Servicio de Hematologia
According to Clinical.Site data, the most researched conditions in "Hospital General de Castellon; Servicio de Hematologia" are
"Chronic Lymphocytic Leukemia" (1 trials), "Leukemia, Lymphocytic, Chronic, B-Cell" (1 trials), "Lymphoma, Non Hodgkin" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Hospital General de Castellon; Servicio de Hematologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital General de Castellon; Servicio de Hematologia
Most popular intervention types in "Hospital General de Castellon; Servicio de Hematologia" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (2 trials), "Cyclophosphamide" (1 trials), "Fludarabine" (1 trials), "bendamustine" (1 trials) and "obinutuzumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital General de Castellon; Servicio de Hematologia
The vast majority of trials in "Hospital General de Castellon; Servicio de Hematologia" are
4 trials for "All" genders.
Clinical Trials Status at Hospital General de Castellon; Servicio de Hematologia
Currently, there are NaN active trials in "Hospital General de Castellon; Servicio de Hematologia".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hospital General de Castellon; Servicio de Hematologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital General de Castellon; Servicio de Hematologia, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".